Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+47.2%
5Y CAGR+31.3%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+47.2%/yr
vs +34.6%/yr prior
5Y CAGR
+31.3%/yr
Recent acceleration
Acceleration
+12.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.9x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $434.24M | +45.1% |
| 2024 | $299.34M | +17.5% |
| 2023 | $254.76M | +87.2% |
| 2022 | $136.08M | +64.6% |
| 2021 | $82.69M | -25.8% |
| 2020 | $111.43M | +139.9% |
| 2019 | $46.44M | +12.0% |
| 2018 | $41.47M | +35.8% |
| 2017 | $30.54M | +134.7% |
| 2016 | $13.01M | - |